CASI Pharmaceuticals, Inc. (CASIF) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $10.08M | -9.6% |
| 2024 | $11.15M | -44.4% |
| 2023 | $20.05M | -26.5% |
| 2022 | $27.28M | +54.9% |
| 2021 | $17.61M | +212.6% |
| 2020 | $5.63M | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $10.08M | -9.6% |
| 2024 | $11.15M | -44.4% |
| 2023 | $20.05M | -26.5% |
| 2022 | $27.28M | +54.9% |
| 2021 | $17.61M | +212.6% |
| 2020 | $5.63M | — |